Elvia Cowan, SVP, FINANCE at Vaxcyte, Inc. (PCVX), sold 24,246 shares at $47.94 ($1.1M) on 2025-12-23, disclosed to the SEC on 2025-12-29.
Open-market sale of $1.1M PCVX by SVP, FINANCE. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,000 | $0 | 0.0% |
| 2 | $47.90 | 4,907 | $235K | 21.1% |
| 3 | $47.90 | 4,907 | $235K | 21.1% |
| 4 | $47.94 | 6,716 | $322K | 28.9% |
| 5 | $47.94 | 6,716 | $322K | 28.9% |
| Total | $45.95 avg | 24,246 |
| $1.1M |
| 100% |
| Filing → |
| PCVX | SELL | 2026-03-18 | $210K | — | Filing → |
| PCVX | SELL | 2026-03-11 | $293K | — | Filing → |
| PCVX | SELL | 2024-09-05 | $538K | — | Filing → |